FDA Warns AstraZeneca on 'Misleading Claims' About COPD Drug
Claims that Breztri has been shown to reduce risk of death in COPD patients are not supported by clinical data, the agency says.
Drug Administration Chronic Obstructive Pulmonary Disease Copd Chronic Obstructive Pulmonary Disease Chronic Obstructive Lung Disease Clinical Research Clinical Trials
Source: medscape.com